BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15068776)

  • 1. Clinical inquiries. Should we discontinue Pap smear screening in women aged>65 years?
    Curran DR; Stigleman S; Neher JO
    J Fam Pract; 2004 Apr; 53(4):308-10. PubMed ID: 15068776
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
    Hsaïri M; Fakhfakh R; Ghyoula M; Ben Abdallah M; Achour N
    Tunis Med; 2000 Oct; 78(10):557-61. PubMed ID: 11190738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost-benefit analysis of the Program for Early Screening of Cervico-uterine Cancer].
    Hernández-Peña P; Lazcano-Ponce EC; Alonso-de Ruiz P; Cruz-Valdez A; Meneses-González F; Hernández-Avila M
    Salud Publica Mex; 1997; 39(4):379-87. PubMed ID: 9381251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Costs and problems in cervix cancer screening are considerably underestimated].
    Bistoletti P
    Lakartidningen; 2000 Aug; 97(32-33):3506-8. PubMed ID: 11037597
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is cervical screening justified in adolescents?].
    Barrasso R; Monsonego J
    Contracept Fertil Sex; 1996 Feb; 24(2):101-3. PubMed ID: 8611929
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for cervical cancer: will women accept less?
    Sirovich BE; Woloshin S; Schwartz LM
    Am J Med; 2005 Feb; 118(2):151-8. PubMed ID: 15694900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the increased sensitivity of the new Papanicolaou (Pap) tests improve the cost-effectiveness of screening for cervical cancer?
    Reust CE
    J Fam Pract; 2001 Feb; 50(2):175. PubMed ID: 11219567
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical inquiries. Is there any benefit to Papanicolaou (Pap) test screening in women who have had a hysterectomy for benign disease?
    Stevermer JJ; Wung L
    J Fam Pract; 2001 Feb; 50(2):111-2. PubMed ID: 11219556
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical inquiries. Is the ThinPrep better than conventional Pap smear at detecting cervical cancer?
    Andy C; Turner LF; Neher JO
    J Fam Pract; 2004 Apr; 53(4):313-5. PubMed ID: 15068777
    [No Abstract]   [Full Text] [Related]  

  • 11. Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina.
    Arrossi S; Ramos S; Paolino M; Sankaranarayanan R
    Reprod Health Matters; 2008 Nov; 16(32):50-8. PubMed ID: 19027622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papanicolaou cervical smears for screening in asymptomatic women.
    Barnes BA
    Prim Care; 1981 Mar; 8(1):131-40. PubMed ID: 6911755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Pap smear rates leave women at risk.
    Golden WE; Hickman N
    J Ark Med Soc; 2004 Jun; 100(12):426-7. PubMed ID: 15200282
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
    Perovic S
    J BUON; 2009; 14(1):93-6. PubMed ID: 19373953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
    Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
    J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cervical cancer screening and associated treatment costs in France].
    Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
    J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
    Koong SL; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S44-7. PubMed ID: 17227642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical smears--an opportunity for disinvestment?
    Spence MT; Woodman C; Collins S; Donnelly B; Desai M
    Br J Gen Pract; 1996 Sep; 46(410):537-8. PubMed ID: 8917874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.